Prevalence, Pathophysiology, and Factors Influencing Renal Outcomes in Patients with Type 1 Diabetes: A Systematic Review

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background: Diabetic kidney disease, which affects up to 40% of those with type 1 diabetes mellitus, significantly increases morbidity and mortality in individuals with type 1 diabetes mellitus. Even with improvements in diabetes treatment, diabetic kidney disease remains a major consequence of chronic hyperglycemia, which damages the kidneys irreversibly. Recent studies emphasize non-albuminuric eGFR decline and acute kidney injury, particularly in children with diabetic ketoacidosis. Ethnic differences significantly complicate the progression of diabetic kidney disease. Objective: The aim is to review recent studies on renal outcomes in type 1 diabetes, with a focus on the incidence of eGFR trajectories, albuminuria evolution, prevalence of CKD, risk factors associated with CKD progression, and the impact of early therapies. Methods: A systematic review that complied with PRISMA 2020 was conducted. Eligible studies were observational studies published in English during the preceding five years that included type 1 diabetes mellitus patients with a diagnosis based on WHO criteria. After screening, ten high-quality studies were selected from the examined databases, including Google Scholar, PMC, and PubMed. The risk of bias was assessed using the NHLBI instrument. Results: Of the 91,296 patients with type 1 diabetes included in the review, 52.64% were male and 47.36% were female. The incidence of albuminuria ranged from 9.8% to 78.9%, and up to 14% of patients had a sharp drop in eGFR. Although it exists, the incidence of end-stage renal disease was comparatively low. Both modifiable risk variables (poor glycemic management, hypertension, dyslipidemia) and non-modifiable ones (diabetic duration, age at onset, and ethnicity) were consistently associated with the advancement of diabetic kidney disease. Conclusion: Diabetic kidney disease is still a serious side effect of type 1 diabetes that calls for better screening and individualised treatment plans. Future studies should improve early intervention strategies, validate predictive biomarkers, and investigate non-albuminuric chronic kidney disease causes.

Article activity feed